Talecris Biotherapeutics Overview

  • Year Founded
  • 1942

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 5,400


  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 6

  • Investments
  • 1

Talecris Biotherapeutics General Information


Provider of plasma-derived protein therapies worldwide. The company develops, produces, markets, and distributes therapies for the people suffering from chronic and acute immune deficiency disorders, alpha-1 antitrypsin deficiency, infectious diseases, hemophilia, and severe burns. Its also offers Hyperimmunes, which are antibody preparations for hepatitis, rabies, tetanus, and treatment of Rh negative women pregnant with Rh positive children; and albumin under various brand names, including Plasbumin albumin and Plasmanate plasma protein factor. In addition, the company provides plasma-derived hemostasis products to treat patients who lack the necessary factors for blood clotting and suffer from conditions in which clotting occurs; and PPF-powder for the fermentation of Kogenate.

Contact Information

Formerly Known As
Bayer AG (Blood Plasma Business)
Ownership Status
Financing Status
Formerly PE-Backed
Primary Industry
Corporate Office
  • 4101 Research Commons
  • 79 T.W. Alexander Drive
  • Durham, NC 27709
  • United States
+1 (919) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Talecris Biotherapeutics Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Talecris Biotherapeutics‘s full profile, request access.

Request a free trial

Talecris Biotherapeutics Executive Team (9)

Name Title Board Seat Contact Info
Bruce Nogales Senior Vice President & General Manager
John Hanson Executive Vice President & Chief Financial Officer
You’re viewing 2 of 9 executive team members. Get the full list »

Talecris Biotherapeutics Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Talecris Biotherapeutics Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Talecris Biotherapeutics‘s full profile, request access.

Request a free trial

Talecris Biotherapeutics Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Talecris Plasma Resources 20-Nov-2006 0000000000 Other Healthcare Services 0000000 0
To view Talecris Biotherapeutics’s complete investments history, request access »

Talecris Biotherapeutics FAQs

  • When was Talecris Biotherapeutics founded?

    Talecris Biotherapeutics was founded in 1942.

  • Where is Talecris Biotherapeutics headquartered?

    Talecris Biotherapeutics is headquartered in Durham, NC.

  • What is the size of Talecris Biotherapeutics?

    Talecris Biotherapeutics has 5,400 total employees.

  • What industry is Talecris Biotherapeutics in?

    Talecris Biotherapeutics’s primary industry is Pharmaceuticals.

  • Is Talecris Biotherapeutics a private or public company?

    Talecris Biotherapeutics is a Private company.

  • What is the current valuation of Talecris Biotherapeutics?

    The current valuation of Talecris Biotherapeutics is 00.00.

  • What is Talecris Biotherapeutics’s current revenue?

    The current revenue for Talecris Biotherapeutics is 000000.

  • How much funding has Talecris Biotherapeutics raised over time?

    Talecris Biotherapeutics has raised $1.12B.

  • Who are Talecris Biotherapeutics’s investors?

    Ampersand Capital Partners and Cerberus Capital Management have invested in Talecris Biotherapeutics.

  • When was Talecris Biotherapeutics acquired?

    Talecris Biotherapeutics was acquired on 02-Jun-2011.

  • Who acquired Talecris Biotherapeutics?

    Talecris Biotherapeutics was acquired by Grifols.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »